Multi-gene engineering: Simultaneous expression and knockdown of six genes off a single platform

被引:30
作者
Greber, David [1 ]
Fussenegger, Martin [1 ]
机构
[1] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland
关键词
firefly luciferase; GFP; heterologous gene regulation; intron-encoded siRNA; macrolide; multi-cistronic; pTRIDENT; RNA silencing; RNAi; SAMY; SEAP; SeXy; siRNA; splicing; streptogramin; tetracycline; VEGF;
D O I
10.1002/bit.21303
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Increases in our understanding of gene function have greatly expanded the repertoire of possible genetic interventions at our disposal with the consequence that many genetic engineering applications require multiple manipulations in which target genes can be both overexpressed and silenced in a simple and co-ordinated manner. Using synthetic introns as a source of encoding short-interfering RNA (siRNA), we demonstrate that it is possible to simultaneously express both a transgene and siRNA from a single polymerase (Pol)II promoter. By encoding siRNA as an intron between two protein domains requiring successful splicing for functionality, it was possible to demonstrate that splicing was occuring, that the coding genes (exonic transgenes) resulted in functional protein, and that the spliced siRNA-containing lariat was capable of modulating expression of a separate target gene. We subsequently extended this concept to develop pTRIDENT-based multi-cistronic vectors that were capable of co-ordinated expression of up to three transgenes of up to three siRNA and three transgenes off a single genetic platform. Such multi-gene engineering technology, enabling concomitant transgene overexpression and target gene knockdown, should be useful for therapeutic gene knockdown, should be useful for therapeutic, biopharmaceutical production, and basic research applications. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:821 / 834
页数:14
相关论文
共 65 条
[1]   MicroRNAs and other tiny endogenous RNAs in C-elegans [J].
Ambros, V ;
Lee, RC ;
Lavanway, A ;
Williams, PT ;
Jewell, D .
CURRENT BIOLOGY, 2003, 13 (10) :807-818
[2]   SECRETED PLACENTAL ALKALINE-PHOSPHATASE - A POWERFUL NEW QUANTITATIVE INDICATOR OF GENE-EXPRESSION IN EUKARYOTIC CELLS [J].
BERGER, J ;
HAUBER, J ;
HAUBER, R ;
GEIGER, R ;
CULLEN, BR .
GENE, 1988, 66 (01) :1-10
[3]   Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins [J].
Boden, D ;
Pusch, O ;
Silbermann, R ;
Lee, F ;
Tucker, L ;
Ramratnam, B .
NUCLEIC ACIDS RESEARCH, 2004, 32 (03) :1154-1158
[4]   Gene- and cell-based therapeutics for type I diabetes mellitus [J].
Bottino, R ;
Lemarchand, P ;
Trucco, M ;
Giannoukakis, N .
GENE THERAPY, 2003, 10 (10) :875-889
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155 [J].
Chung, Kwan-Ho ;
Hart, Christopher C. ;
Al-Bassam, Sarmad ;
Avery, Adam ;
Taylor, Jennifer ;
Patel, Paresh D. ;
Vojtek, Anne B. ;
Turner, David L. .
NUCLEIC ACIDS RESEARCH, 2006, 34 (07)
[7]   RNA interference is mediated by 21-and 22-nucleotide RNAs [J].
Elbashir, SM ;
Lendeckel, W ;
Tuschl, T .
GENES & DEVELOPMENT, 2001, 15 (02) :188-200
[8]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[9]   Osteoarthritis gene therapy [J].
Evans, CH ;
Gouze, JN ;
Gouze, E ;
Robbins, PD ;
Ghivizzani, SC .
GENE THERAPY, 2004, 11 (04) :379-389
[10]   Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting [J].
Fedoriw, AM ;
Stein, P ;
Svoboda, P ;
Schultz, RM ;
Bartolomei, MS .
SCIENCE, 2004, 303 (5655) :238-240